AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline

Go back to AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline
AbbVie (NYSE: ABBV) Delayed: 227.60 +2.83 (1.26%)
Previous Close $224.77    52 Week High $68.12 
Open $227.31    52 Week Low $50.71 
Day High $228.40    P/E 49.37 
Day Low $226.39    EPS $4.61 
Volume 314,544